2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine has been researched along with Carcinoma, Hepatocellular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabibbo, A; Ciapponi, L; Ciliberto, G; Klein, B; Lahm, A; Paonessa, G; Pulkki, K; Savino, R; Sporeno, E; Sun, RX; Toniatti, C | 1 |
1 other study(ies) available for 2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine and Carcinoma, Hepatocellular
Article | Year |
---|---|
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
Topics: Antigens, CD; Carcinoma, Hepatocellular; Growth Inhibitors; Humans; Interleukin-6; Liver Neoplasms; Melanoma; Models, Molecular; Morpholines; Multiple Myeloma; Neoplasm Proteins; Peptide Fragments; Polymerase Chain Reaction; Protein Conformation; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |